July 09, 2014 10:06 PM ET


Company Overview of Penwest Pharmaceuticals Co.

Company Overview

Penwest Pharmaceuticals Co., a drug development company, identifies and develops products primarily for disorders of the nervous system. Its proprietary drug delivery technologies include TIMERx, a controlled-release technology; Geminex, a technology enabling drug release at two different rates; SyncroDose, a technology enabling controlled release at the appropriate site in the body; and GastroDose system, a technology enabling drug delivery to the upper gastrointestinal tract. The company offers Opana ER, an oral extended release opioid analgesic for patients with moderate to severe pain requiring continuous opioid treatment using its TIMERx drug delivery technology; and Nifedipine XL, a ge...

2981 Route 22

Suite 2

Patterson, NY 12563-2335

United States

Founded in 1991

39 Employees





Key Executives for Penwest Pharmaceuticals Co.

Chief Medical Officer and Senior Vice President of Clinical Development & Regulatory
Age: 61
Senior Vice President of Pharmaceutical Development
Age: 60
Chief Accounting Officer
Age: 57
Senior Director of Clinical Development
Age: 51
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Xellia Pharmaceuticals, Inc. United States
4P Therapeutics LLC United States
Cequent Pharmaceuticals, Inc. United States
Cyterix Pharmaceuticals Inc. United States
Vicus Therapeutics LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Penwest Pharmaceuticals Co., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.